c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
ImmunityBio (IBRX) Q3 Earnings Miss Expectations Amid High Price-to-Sales Ratio
GuruFocus | Nov 9, 2026 8:00 AM EST
Related Stocks: IBRX ,
Read original article